Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study
Abstract Background Evidence suggests that Greece is among the European countries with increased trend in HCV prevalence among injecting drug users (IDUs) from 2008 to 2014. Nonetheless, the access of IDUs to treatment for Hepatitis C Virus (HCV) is very limited while the risk of co-infection and tr...
Saved in:
Main Authors: | Kyriakos Souliotis (Author), Eirini Agapidaki (Author), Manto Papageorgiou (Author), Niki Voudouri (Author), Xenophon Contiades (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Access to Care for Multiple Sclerosis in Times of Economic Crisis in Greece - the HOPE II Study
by: Kyriakos Souliotis, et al.
Published: (2016) -
Health Democracy Index: Development and Validation of a Self-Reported Instrument for Measuring Patient Participation in Health Policy
by: Kyriakos Souliotis, et al.
Published: (2018) -
Pharmaceutical pricing policy in Greece: towards a different path.
by: Kyriakos Souliotis, et al.
Published: (2016) -
Assessing Patient Participation in Health Policy Decision-Making in Cyprus
by: Kyriakos Souliotis, et al.
Published: (2016) -
Estimating the fiscal effects of public pharmaceutical expenditure reduction in Greece
by: Kyriakos eSouliotis, et al.
Published: (2015)